No Image

IIBA Announces The Business Analysis Standard

IIBA’s Business Analysis Standard is a new resource developed with input from the global business analysis community to address current practice needs TORONTO, Nov. 30, 2022 (GLOBE NEWSWIRE) — The International Institute of Business Analysis™ (IIBA®) is the global association leading the business analysis community and professional standards...
read more
No Image

IIBA Announces The Business Analysis Standard

IIBA’s Business Analysis Standard is a new resource developed with input from the global business analysis community to address current practice needs TORONTO, Nov. 30, 2022 (GLOBE NEWSWIRE) — The International Institute of Business Analysis™ (IIBA®) is...
read more
No Image

Kiteworks Releases Its 2023 Forecast for Managing Private Content Exposure Risk Report

15 predictions on data privacy and compliance that provide guidance to IT, security, risk, and compliance leaders in 2023 PALO ALTO, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) — Kiteworks, which delivers data privacy and compliance for sensitive content communic...
read more
No Image

Kiteworks Releases Its 2023 Forecast for Managing Private Content Exposure Risk Report

15 predictions on data privacy and compliance that provide guidance to IT, security, risk, and compliance leaders in 2023 PALO ALTO, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) — Kiteworks, which delivers data privacy and compliance for sensitive content communic...
read more
No Image

Aqualia Selects Cority Safety Essentials Solution

Leading European water management company seeks to bolster global health and safety program with integrated digital solution Cority logo TORONTO, Nov. 30, 2022 (GLOBE NEWSWIRE) — Global enterprise EHS (Environmental, Health, and Safety) software provider Cor...
read more
No Image

Aqualia Selects Cority Safety Essentials Solution

Leading European water management company seeks to bolster global health and safety program with integrated digital solution Cority logo TORONTO, Nov. 30, 2022 (GLOBE NEWSWIRE) — Global enterprise EHS (Environmental, Health, and Safety) software provider Cor...
read more
No Image

AUM Biosciences Receives FDA Orphan Drug Designation for AUM302 for the Treatment of Neuroblastoma

AUM302 has potential to be the first multi-kinase inhibitor class of drug in Neuroblastoma SINGAPORE and BETHESDA, Md., Nov. 30, 2022 (GLOBE NEWSWIRE) — AUM Biosciences Pte. Ltd. (“AUM”), a global clinical-stage biotech company focused on discovering and...
read more
No Image

AUM Biosciences Receives FDA Orphan Drug Designation for AUM302 for the Treatment of Neuroblastoma

AUM302 has potential to be the first multi-kinase inhibitor class of drug in Neuroblastoma SINGAPORE and BETHESDA, Md., Nov. 30, 2022 (GLOBE NEWSWIRE) — AUM Biosciences Pte. Ltd. (“AUM”), a global clinical-stage biotech company focused on discovering and...
read more
1 2 3 45